As on Wednesday, Procept BioRobotics Corp (NASDAQ: PRCT) started slowly as it slid -0.38% to $51.79, before settling in for the price of $51.99 at the close. Taking a more long-term approach, PRCT posted a 52-week range of $24.83-$54.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 142.74%. Meanwhile, its Annual Earning per share during the time was -23.27%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.62%. This publicly-traded company’s shares outstanding now amounts to $50.77 million, simultaneously with a float of $48.57 million. The organization now has a market capitalization sitting at $2.64 billion. At the time of writing, stock’s 50-day Moving Average stood at $49.04, while the 200-day Moving Average is $39.21.
Procept BioRobotics Corp (PRCT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Procept BioRobotics Corp’s current insider ownership accounts for 4.69%, in contrast to 88.88% institutional ownership. According to the most recent insider trade that took place on Mar 18 ’24, this organization’s President, CEO sold 5,391 shares at the rate of 48.83, making the entire transaction reach 263,243 in total value, affecting insider ownership by 241,319. Preceding that transaction, on Mar 18 ’24, Company’s EVP, CFO sold 1,024 for 48.83, making the whole transaction’s value amount to 50,002. This particular insider is now the holder of 102,149 in total.
Procept BioRobotics Corp (PRCT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 27.64 per share during the current fiscal year.
Procept BioRobotics Corp’s EPS increase for this current 12-month fiscal period is 10.62% and is forecasted to reach -1.52 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.80% through the next 5 years, which can be compared against the -23.27% growth it accomplished over the previous five years trading on the market.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Let’s observe the current performance indicators for Procept BioRobotics Corp (PRCT). It’s Quick Ratio in the last reported quarter now stands at 6.77. The Stock has managed to achieve an average true range (ATR) of 2.24. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 19.38.
In the same vein, PRCT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.25, a figure that is expected to reach -0.55 in the next quarter, and analysts are predicting that it will be -1.52 at the market close of one year from today.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Through scrutinizing the latest numbers posted by the [Procept BioRobotics Corp, PRCT], it can be observed that its last 5-days Average volume of 0.57 million was better the volume of 0.49 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 65.86% While, its Average True Range was 2.25.
Raw Stochastic average of Procept BioRobotics Corp (PRCT) in the period of the previous 100 days is set at 87.13%, which indicates a major rise in contrast to 69.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 46.08% that was lower than 46.39% volatility it exhibited in the past 100-days period.
